The global GLP-1 receptor agonist market is projected to reach USD 78.4 billion by 2032, growing at a CAGR of 3.66%. The expansion is driven by increasing demand for effective metabolic disorder treatments, including diabetes and obesity management. As per MarkNtel Advisors,
Read More : https://www.prnewswire.co....
GLP-1 Receptor Agonist Market to Hit USD 78.4 Billion by 2032, Growing at a CAGR of 3.66% with Rising Demand for Metabolic Disease Therapies | MarkNtel Advisors
/PRNewswire/ -- According to the in-depth study published by MarkNtel Advisors, the Global GLP-1 Receptor Agonist Market is projected to grow at a CAGR of...
https://www.prnewswire.co.uk/news-releases/glp-1-receptor-agonist-market-to-hit-usd-78-4-billion-by-2032--growing-at-a-cagr-of-3-66-with-rising-demand-for-metabolic-disease-therapies--markntel-advisors-302714587.htmlWho to follow
